Takeda's rare disease drug's manufacturing and supply woes continue as FDA rejects supplement
Almost 3 years after Takeda had to recall a drug that can help people with the rare condition known as hypoparathyroidism, those waiting for any …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
